Paul A. Friedman
2020 - Synta Pharmaceuticals
In 2020, Paul A. Friedman earned a total compensation of $4.5M as Chairman and Chief Executive Officer at Synta Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $463,446 |
|---|---|
| Option Awards | $3,468,500 |
| Salary | $603,500 |
| Total | $4,535,446 |
Friedman received $3.5M in option awards, accounting for 76% of the total pay in 2020.
Friedman also received $463.4K in non-equity incentive plan and $603.5K in salary.
Rankings
In 2020, Paul A. Friedman's compensation ranked 2,477th out of 13,090 executives tracked by ExecPay. In other words, Friedman earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,477 out of 13,090 | 81st |
Division Manufacturing | 948 out of 5,624 | 83rd |
Major group Chemicals And Allied Products | 341 out of 2,257 | 85th |
Industry group Drugs | 292 out of 1,957 | 85th |
Industry Pharmaceutical Preparations | 211 out of 1,462 | 86th |
Source: SEC filing on May 2, 2022.
Friedman's colleagues
We found four more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2020.